Warner Bros. Discovery, Inc.
BICYCLIC COMPOUND AS RIP-1 KINASE INHIBITOR AND APPLICATION THEREOF
Last updated:
Abstract:
A compound represented by formula (I), isomers or pharmaceutically acceptable salts thereof, and application thereof in the preparation of drugs for treating diseases related to RIP-1 (receptor interacting protein) kinase. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
29 May 2020
Issue date:
4 Aug 2022